GLP1R and infection: The rate of sepsis- or infection-related mortality was 3.01 per 100 person-years (95% CI, 2.88-3.13 per 100 person-years) in the DPP-4 inhibitor group and 1.80 per 100 person-years (95% CI, 1.07-2.53 per 100 person-years) in the GLP-1 receptor agonist group.